170 related articles for article (PubMed ID: 6194812)
21. Natural protease inhibitors to fibrinolysis in liver diseases.
Arnman R; Gyzander E; Hedner U; Olsson R; Teger-Nilsson AC
Hepatogastroenterology; 1980 Aug; 27(4):254-8. PubMed ID: 6162766
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
[TBL] [Abstract][Full Text] [Related]
23. [Protease inhibitors].
Lambin P
Rev Fr Transfus Immunohematol; 1980 May; 23(2):147-83. PubMed ID: 6161406
[No Abstract] [Full Text] [Related]
24. Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of pre-eclampsia.
Condie RG; Ogston D
Br J Obstet Gynaecol; 1976 Dec; 83(12):938-42. PubMed ID: 64256
[TBL] [Abstract][Full Text] [Related]
25. [A case report of hereditary angioedema and studies on the serum components of complement, C1-inactivator and proteinase inhibitors during edema attack].
Mikami A; Kohno M
Hokkaido Igaku Zasshi; 1987 May; 62(3):497-500. PubMed ID: 3610041
[TBL] [Abstract][Full Text] [Related]
26. The study of local fibrinolysis in abortion.
Ikeuchi M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1215-23. PubMed ID: 2411832
[TBL] [Abstract][Full Text] [Related]
27. The behavior of antithrombin III, alpha 2 macroglobulin, and alpha 1 antitrypsin during cardiopulmonary bypass.
Pickering NJ; Brody JI; Fink GB; Finnegan JO; Ablaza S
Am J Clin Pathol; 1983 Oct; 80(4):459-64. PubMed ID: 6194683
[TBL] [Abstract][Full Text] [Related]
28. [Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)].
Matsuda T
Rinsho Ketsueki; 1978 Jul; 19(7):947-54. PubMed ID: 81330
[No Abstract] [Full Text] [Related]
29. [Activity of selected proteinase inhibitors in patients with disorders of lipid metabolism].
Kopieczna-Grzebieniak E; Drózdz M; Grabowska-Bochenek R; Piekarski M
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):12-4. PubMed ID: 1384011
[TBL] [Abstract][Full Text] [Related]
30. Studies of protease inhibitors in the sera of patients with amyotrophic lateral sclerosis.
Adachi N; Shoji S
J Neurol Sci; 1989 Feb; 89(2-3):165-8. PubMed ID: 2466958
[TBL] [Abstract][Full Text] [Related]
31. Immunological studies of plasma protease inhibitors associated with human blood platelets.
Endresen GK
Thromb Res; 1980 Jul 1-15; 19(1-2):157-63. PubMed ID: 6160634
[No Abstract] [Full Text] [Related]
32. The determination of antithrombin III, alpha 2-macroglobulin and alpha 2-antiplasmin in plasma by laser nephelometry.
Schmitz-Huebner U; Nachbar J; Asbeck F
J Clin Chem Clin Biochem; 1980 Apr; 18(4):221-5. PubMed ID: 6155426
[TBL] [Abstract][Full Text] [Related]
33. Coagulation factors and proteinase inhibitors in the plasma of children with acute lymphoblastic leukoses. Behaviour before and during treatment according to Protocol I of the Cooperative Leukaemia Study COALL-80.
Reitz M; Witzke G; Egbring R; Gutjahr P
Klin Wochenschr; 1984 Dec; 62(24):1165-9. PubMed ID: 6085131
[TBL] [Abstract][Full Text] [Related]
34. [Proteinase inhibitors and fibrinogen split products in patients with malignant diseases (author's transl)].
Schwarz HP; Aiginger P; Kuzmits R
Acta Med Austriaca; 1981; 8(1):22-5. PubMed ID: 6165218
[TBL] [Abstract][Full Text] [Related]
35. Circulating antithrombins in pregnancy.
Teisner B; Davey MW; Grudzinskas JG
Br J Obstet Gynaecol; 1982 Jan; 89(1):62-4. PubMed ID: 6174143
[TBL] [Abstract][Full Text] [Related]
36. Partial primary structure of human alpha 2-antiplasmin-homology with other plasma protease inhibitors.
Lijnen HR; Wiman B; Collen D
Thromb Haemost; 1982 Dec; 48(3):311-4. PubMed ID: 6984543
[TBL] [Abstract][Full Text] [Related]
37. Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.
Rao AK; Schmaier AH; Colman RW
Pathobiol Annu; 1982; 12():35-64. PubMed ID: 6186978
[No Abstract] [Full Text] [Related]
38. Protease inhibitors in liver disease.
Sinclair TS; Booth NA; Penman SM; Brunt PW; Mowat NA; Bennett NB
Scand J Gastroenterol; 1988 Jun; 23(5):620-4. PubMed ID: 2456604
[TBL] [Abstract][Full Text] [Related]
39. Proteases and protease inhibitors in taurocholate-induced acute pancreatitis in rats.
Kruse P; Hage E; Lasson A
Int J Pancreatol; 1999 Apr; 25(2):113-21. PubMed ID: 10360224
[TBL] [Abstract][Full Text] [Related]
40. [Pi phenotypes of alpha-1-antitrypsin and antiproteases in meningococcal sepsis].
Ruiz C; Blanco Quirós A; Solís P; Alvarez Guisasola J; Sánchez Villares E
An Esp Pediatr; 1983 Oct; 19(4):268-78. PubMed ID: 6197915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
